Physician profile
John D Wheeler
NPI 1780641795
$4,910.07
in general payments reported to CMS, 2019-2025
44 companies · $791 in 2025
The $791 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $410 · 2020: $341 · 2021: $1,011 · 2022: $877 · 2023: $1,062 · 2024: $418 · 2025: $791.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,198 · Education: $72.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,197.89 |
| Education | $72.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $710.30 | 2019-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $474.54 | 2019-2024 | |
| Aspira Women'S Health INC | $317.00 | 2021-2023 | Ova1 |
| Abbvie INC. | $305.93 | 2019-2023 | Liletta, Orilissa, Lo Loestrin Fe |
| Channel Medsystems, INC. | $280.72 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $273.16 | 2023-2025 | Gemtesa, Myfembree |
| Exeltis, USA INC. | $205.94 | 2019-2025 | Slynd |
| Sage Therapeutics, LLC | $186.00 | 2025 | Zurzuvae |
| Daiichi Sankyo INC. | $182.50 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $180.02 | 2019-2025 | |
| Caldera Medical, INC | $178.50 | 2021 | |
| Mayne Pharma Commercial LLC | $140.52 | 2021-2025 | |
| Conmed Corporation | $130.30 | 2023 | Airseal |
| Axonics, INC. | $127.87 | 2024 | Axonics |
| Intuitive Surgical, INC. | $104.14 | 2021-2023 | Da Vinci Surgical System |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $92.51 | 2019-2021 | |
| Millicent US INC | $85.02 | 2024-2025 | Femlyv, Intrarosa, Femring |
| Myovant Sciences INC. | $82.31 | 2021-2022 | |
| Amgen INC. | $82.17 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $71.93 | 2025 | Qelbree |
| Janssen Pharmaceuticals, INC | $68.76 | 2023 | Xarelto |
| Organon LLC | $64.88 | 2023-2025 | Nexplanon, Nuvaring, Jada System |
| Mylan Pharmaceuticals INC. | $58.85 | 2019-2022 | |
| Novo Nordisk INC | $56.73 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Becton, Dickinson and Company | $49.81 | 2022-2025 | Arista |
| Urovant Sciences INC | $46.29 | 2021-2022 | |
| Boston Scientific Corporation | $38.64 | 2024 | Solyx Sis System |
| Minerva Surgical, INC | $31.07 | 2022-2023 | |
| Evofem Biosciences, INC. | $28.42 | 2021-2023 | Phexxi |
| Smith+Nephew, INC. | $27.35 | 2021-2022 | |
| Dysis Medical, INC. | $22.50 | 2019 | |
| Coopersurgical, INC. | $20.51 | 2019 | |
| Therapeuticsmd, INC. | $18.64 | 2019 | |
| Convatec INC. | $18.24 | 2022 | |
| Roche Diagnostics Corporation | $17.72 | 2020 | |
| Sandoz INC. | $16.71 | 2025 | Jubbonti |
| Coloplast Corp | $16.43 | 2021 | |
| Scynexis, INC. | $15.71 | 2022 | |
| Agile Therapeutics, INC. | $15.69 | 2021 | |
| Tactile Systems Technology INC | $14.79 | 2025 | Nimbl, Flexitouch Plus |
| Merck Sharp & Dohme LLC | $13.83 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.02 | 2023 | Seglentis |
| Amag Pharmaceuticals, INC. | $12.48 | 2019 | |
| Sanara Medtech INC. | $11.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Wheeler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.